According to The Times of India, as well as sources close to the matter, Sun Pharmaceutical may phase out the Ranbaxy brand on generic drugs in the US after completing its $3.2-billion acquisition of the company. The people familiar with the ... FirstWord Pharma, 6 days ago
Sun Pharma to pay $3.2 billion for Ranbaxy, will be world No. 5 - Times of India, 1 week ago
MUMBAI: The Ranbaxy brand may be allowed to die a slow death over the next two to three years by the company's new owner - Sun Pharma - due to the negativity surrounding its product quality. Sun Pharma announced on Monday that it will buy the ...Times of India, 1 week ago RANBAXY LABORATORIES : Sun may let Ranbaxy brand die a slow death 4 Traders, 5 days ago
on your WebpageAdd Widget >Get your members hooked!